The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells

Experimental Cell Research

Volumn 317, Issue 18, 2011, Pages 2661-2670

  Wei, Feng ^a   Wang, Tingzhong ^a   Liu, Juanjuan ^b   Du, Yuan ^a   Ma, Aiqun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b Hospital of China Railway First Group   (China)

Author keywords

5 azacytidine; Biological characteristic; Cardiomyocyte; Differentiation; Mesenchymal stem cell

Indexed keywords

ALPHA ACTIN; AZACITIDINE; HERMES ANTIGEN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TROPONIN T;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL CLONING; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SUBPOPULATION; CHONDROGENESIS; CONTROLLED STUDY; HEART MUSCLE CELL; MESENCHYMAL STEM CELL; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT;

EID: 80053617123     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.08.011     Document Type: Article

References (38)

1. Fedak P.W., Verma S., Weisel R.D., Li R.K. Cardiac remodeling and failure: from molecules to man (part I). Cardiovasc. Pathol. 2005, 14:1-11.
2. Hare J.M., Traverse J.H., Henry T.D., Dib N., Strumpf R.K., Schulman S.P., Gerstenblith G., DeMaria A.N., Denktas A.E., Gammon R.S., Hermiller J.B., Reisman M.A., Schaer G.L., Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 2009, 54:2277-2286.
3. Grauss R.W., van Tuyn J., Steendijk P., Winter E.M., Pijnappels D.A., Hogers B., Groot A., van der Geest R., van der Laarse A., de Vries A.A.F., Schalij M.J., Atsmaa D.E. Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts. Stem Cells 2008, 26:1083-1093.
4. Jin J.Y., Jeong S.I., Shin Y.M., Lim K.S., Shin H.S., Lee Y.M., Koh H.C., Kim K.S. Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur. J. Heart Fail. 2009, 11:147-153.
5. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., Ishino K., Ishida H., Shimizu T., Kangawa K. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 2006, 12:459-465.
6. Tsuji H., Miyoshi S., Ikegami Y., Hida N., Asada H., Togashi I., Suzuki J., Satake M., Nakamizo H., Tanaka M., Mori T., Segawa K., Nishiyama N., Inoue J., Makino H., Miyado K., Ogawa S., Yoshimura Y., Umezawa A. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ. Res. 2010, 106:1613-1623.
7. Amado L., Saliaris A., Schuleri K., St John M., Xie J., Cattaneo S., Durand D., Fitton T., Kuang J., Stewart G. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 2005, 102:11474-11479.
8. Yang J.F., Zhou W.W., Zheng W., Ma Y.L., Lin L., Tang T., Liu J.X., Yu J.F., Zhou X.M., Hu J.G. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 2007, 107:17-29.
9. Tang J., Wang J., Yang J., Kong X., Zheng F., Guo L., Zhang L., Huang Y. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur. J. Cardio-Thorac 2009, 36:644-650.
10. Silva G., Litovsky S., Assad J., Sousa A., Martin B., Vela D., Coulter S., Lin J., Ober J., Vaughn W. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005, 111:150-156.
11. Mias C., Lairez O., Trouche E., Roncalli J., Calise D., Seguelas M.H., Ordener C., Piercecchi-Marti M.D., Auge N., Salvayre A.N., Bourin P., Parini A., Cussac D. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 2009, 27:2734-2743.
12. Li L.L., Zhang Y., Li Y.L., Yu B., Xu Y., Zhao S.D., Guan Z.Z. Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transpl. Int. 2008, 21:1181-1189.
13. Gnecchi M., He H.M., Noiseux N., Liang O.D., Zhang L.M., Morello F., Mu H., Melo L.G., Pratt R.E., Ingwall J.S., Dzau V.J. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. Faseb J. 2006, 20:661-669.
14. Mirotsou M., Zhang Z.Y., Deb A., Zhang L.N., Gnecchi M., Noiseux N., Mu H., Pachori A., Dzau V. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl. Acad. Sci. USA 2007, 104:1643-1648.
15. Sadat S., Gehmert S., Song Y.H., Yen Y.S., Bai X.W., Gaiser S., Klein H., Alt E. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-1 and VEGF. Biochem. Biophys. Res. Commun. 2007, 363:674-679.
16. DiGirolamo C., Stokes D., Colter D., Phinney D., Class R., Prockop D. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 1999, 107:275-281.
17. Russell K.C., Phinney D.G., Lacey M.R., Barrilleaux B.L., Meyertholen K.E., O'Connor K.C. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 2010, 28:788-798.
18. Muraglia A., Cancedda R., Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J. Cell Sci. 2000, 113:1161-1166.
19. Phinney D. Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy. Cell Cycle 2007, 6:2884-2889.
20. I.-P.E., Antonitsis P., Kaidoglou A., Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact. Cardiovasc. Thorac. Surg. 2007, 593-597.
21. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., Sano M., Takahashi T., Hori S., Abe H., Hata J., Umezawa A., Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Investig. 1999, 103:697-705.
22. Martin-Rendon E., Sweeney D., Lu F., Girdlestone J., Navarrete C., Watt S.M. 5-azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang. 2008, 95:137-148.
23. Bae S., Shim S.H., Park C.W., Son H.K., Lee H.J., Son J.Y., Jeon C., Kim H. Combined omics analysis identifies transmembrane 4 L6 family member 1 as a surface protein marker specific to human mesenchymal stem cells. Stem Cells Dev. 2011, 20:197-203.
24. Kaltz N., Ringe J., Holzwarth C., Charbord P., Niemeyer M., Jacobs V.R., Peschel C., Haupl T., Oostendorp R.A.J. Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sources. Exp. Cell Res. 2010, 316:2609-2617.
25. Halfon S., Abramov N., Grinblat B., Ginis I. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 2011, 20:53-66.
26. Tamai K., Yamazaki T., Chino T., Ishii M., Otsuru S., Kikuchi Y., Iinuma S., Saga K., Nimura K., Shimbo T. PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc. Natl. Acad. Sci. USA 2011, 108:296-301.
27. Wang T., Xu Z., Jiang W., Ma A. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int. J. Cardiol. 2006, 109:74-81.
28. Chang M.G., Tung L., Sekar R.B., Chang C.Y., Cysyk J., Dong P.H., Marban E., Abraham R. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation 2006, 113:1832-1841.
29. Caplan A., Dennis J. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 2006, 98:1076-1084.
30. Kawada H., Fujita J., Kinjo K., Matsuzaki Y., Tsuma M., Miyatake H., Muguruma Y., Tsuboi K., Itabashi Y., Ikeda Y., Ogawa S., Okano H., Hotta T., Ando K., Fukuda K. Nonhematopoletic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 2004, 104:3581-3587.
31. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
32. Xu W.R., Zhang X.R., Qian H., Zhu W., Sun X.C., Hu J., Zhou H., Chen Y.C. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp. Biol. Med. 2004, 229:623-631.
33. Tomita Y., Makino S., Hakuno D., Hattan N., Kimura K., Miyoshi S., Murata M., Ieda M., Fukuda K. Application of mesenchymal stem cell-derived cardiomyocytes as bio-pacemakers: current status and problems to be solved. Med. Biol. Eng. Comput. 2007, 45:209-220.
34. Matsuura K., Nagai T., Nishigaki N., Oyama T., Nishi J., Wada H., Sano M., Toko H., Akazawa H., Sato T., Nakaya H., Kasanuki H., Komuro I. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem. 2004, 279:11384-11391.
35. Bearzi C., Rota M., Hosoda T., Tillmanns J., Nascirnbene A., De Angelis A., Yasuzawa-Amano S., Trofimova I., Siggins R.W., LeCapitaine N., Cascapera S., Beltrami A.P., D'Alessandro D.A., Zias E., Quaini F., Urbanek K., Michler R.E., Bolli R., Kajstura J., Leri A., Anversa P. Human cardiac stem cells. Proc. Natl. Acad. Sci. USA 2007, 104:14068-14073.
36. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
37. Dai Y., Ashraf M., Zuo S., Uemura R., Dai Y.S., Wang Y.G., Haider H.K., Li T.Y., Xu M.F. Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair. J. Mol. Cell. Cardiol. 2008, 44:607-617.
38. Kucia M., Dawn B., Hunt G., Guo Y.R., Wysoczynski M., Majka M., Ratajczak J., Rezzoug F., Ildstad S.T., Bolli R., Ratajczak M.Z. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ. Res. 2004, 95:1191-1199.